<DOC>
	<DOC>NCT01301469</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of HES 130/0.42 in an electrolyte infusion in comparison to HES 130/0.4 in a sodium chloride infusion.</brief_summary>
	<brief_title>Comparison of HES 130 in Balanced and in Unbalanced Solution</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion: Male or female (non pregnant) patients; between 18 and 70 years Elective noncardiac surgery (except pancreatic or neurological surgery) with an estimated operation duration of 2 hours or longer General anesthesia Voluntary consent Exclusion: Patients of ASAclass III or IV, Cardiac insufficiency NYHA classes III. IV BMI &lt; 18 or &gt; 29 Patients with daily urine output &lt; 1L Patients on hemodialysis Abnormal liver or renal function (i. e. above upper limit of normal range) Abnormal coagulation function (prothrombin time (PT) 3 seconds higher than normal or activated partial thromboplastin time (APTT) 10 seconds higher than normal) Hgb &lt; 10g/dl or HCT &lt; 30% Potassium, sodium or chloride above the upper limit of normal of the laboratory History of diabetes mellitus Known history of a mental or neurological disorder, such as epileptic seizures. History of hypertension and/or taking a betareceptor blocker or history of atrial fibrillation Patients with known hypersensitivity and with contraindications to HES or any of the excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>